Ali Sleiman – General Manager, AbbVie Egypt & Levant
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
AbbVie aims to advance patient care globally across six therapeutic areas: immunology, kidney disease, liver disease, neuroscience, oncology, and women’s health. With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches in the United Arab Emirates with a strong commitment to the region’s healthcare.3
Contact
90th Street, Plot 76, 1st Sector, 5th Settlement, New Cairo, P.O.: 11835, Egypt, 5th Settlement, Cairo
Tel: (20-2) 2614-5800
Fax: 26145891
Web: abbvie.com
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
Abbvie has taking a leading role in the Egyptian pharmaceutical industry by bringing their new all-oral hepatitis C treatment to Egypt, the country with the highest prevalence of the disease…
Dr. Rostom, Deputy Head of the pharmaceutical chamber of the Federation of Egyptian Industries explains Egypt’s unique potential for investors and discusses key issues to be addressed in order to…
The President and the Counselor of the French Chamber of Commerce and Industry in Egypt, discuss plans to establish a French industrial zone in Alexandria (North of Egypt) to further…
Egypt is back in business, with economic growth and investor confidence in Egypt nearly back to levels seen in 2010, GDP growth up to four percent, and several high profile…
His Excellency, Professor Dr. Hatem El Gabaly, the minister of health and population of Egypt, shows no doubt that the strong and necessary reform his government is currently undertaking…
See our Cookie Privacy Policy Here
